Andrew Fein
Stock Analyst at HC Wainwright & Co.
(2.14)
# 2,792
Out of 4,884 analysts
632
Total ratings
42.63%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CADL Candel Therapeutics | Assumes: Buy | $23 | $5.10 | +350.98% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $44.79 | +33.96% | 8 | Jun 26, 2025 | |
| BIIB Biogen | Reiterates: Buy | $187 | $132.87 | +40.74% | 21 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $20.95 | +52.74% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $459.62 | +19.66% | 27 | Jun 23, 2025 | |
| INSM Insmed | Maintains: Buy | $90 → $120 | $97.80 | +22.70% | 15 | Jun 11, 2025 | |
| PEPG PepGen | Maintains: Buy | $14 → $8 | $1.22 | +555.74% | 13 | May 29, 2025 | |
| SVRA Savara | Downgrades: Neutral | $6 → $2 | $2.19 | -8.68% | 13 | May 29, 2025 | |
| LQDA Liquidia | Maintains: Buy | $29 → $35 | $12.19 | +187.12% | 14 | May 28, 2025 | |
| VIGL Vigil Neuroscience | Downgrades: Neutral | $14 → $8 | $7.99 | +0.13% | 14 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $6.44 | +117.56% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $11.48 | +204.88% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $2.89 | +384.43% | 15 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $20.37 | +268.28% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $29.17 | +133.12% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.51 | +562.25% | 10 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $8.76 | +333.79% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $6.30 | +153.97% | 20 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $13.45 | +85.87% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $14.69 | +117.84% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.94 | +235.57% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $425 | $294.49 | +44.32% | 15 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $11.60 | +37.93% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $7.95 | +201.89% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $135 | $128.35 | +5.18% | 18 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.07 | +479.71% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $24.12 | +57.55% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.72 | +194.12% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $129.11 | +30.12% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $2.15 | +225.58% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $1.16 | +848.28% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.26 | +693.65% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $6.95 | +216.55% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $0.76 | +162.05% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $11.98 | +66.94% | 14 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $2.18 | +450.46% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.13 | +153.41% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.88 | +39.59% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $2.89 | +695.85% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.51 | +893.38% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $53.82 | +57.93% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $21.46 | +63.09% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $6.92 | -42.20% | 17 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $7.71 | +872.76% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $26.90 | +178.81% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.29 | +2,631.31% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $1.48 | +372.97% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.53 | +53.14% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $2.68 | +1,392.54% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.92 | +16,254.12% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $16.73 | +258.64% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $4.30 | +248.84% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.74 | +2,198.85% | 3 | Mar 16, 2022 |
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $5.10
Upside: +350.98%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $44.79
Upside: +33.96%
Biogen
Jun 26, 2025
Reiterates: Buy
Price Target: $187
Current: $132.87
Upside: +40.74%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $20.95
Upside: +52.74%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $459.62
Upside: +19.66%
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $97.80
Upside: +22.70%
PepGen
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $1.22
Upside: +555.74%
Savara
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $2.19
Upside: -8.68%
Liquidia
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $12.19
Upside: +187.12%
Vigil Neuroscience
May 27, 2025
Downgrades: Neutral
Price Target: $14 → $8
Current: $7.99
Upside: +0.13%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $6.44
Upside: +117.56%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $11.48
Upside: +204.88%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $2.89
Upside: +384.43%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $20.37
Upside: +268.28%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $29.17
Upside: +133.12%
May 9, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $1.51
Upside: +562.25%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $8.76
Upside: +333.79%
May 9, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $6.30
Upside: +153.97%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $13.45
Upside: +85.87%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $14.69
Upside: +117.84%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $8.94
Upside: +235.57%
May 5, 2025
Reiterates: Buy
Price Target: $425
Current: $294.49
Upside: +44.32%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $11.60
Upside: +37.93%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $7.95
Upside: +201.89%
May 2, 2025
Reiterates: Buy
Price Target: $135
Current: $128.35
Upside: +5.18%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.07
Upside: +479.71%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $24.12
Upside: +57.55%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.72
Upside: +194.12%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $129.11
Upside: +30.12%
Apr 4, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $2.15
Upside: +225.58%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.16
Upside: +848.28%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.26
Upside: +693.65%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $6.95
Upside: +216.55%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $0.76
Upside: +162.05%
Mar 14, 2025
Reiterates: Buy
Price Target: $20
Current: $11.98
Upside: +66.94%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $2.18
Upside: +450.46%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $5.13
Upside: +153.41%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $7.88
Upside: +39.59%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $2.89
Upside: +695.85%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.51
Upside: +893.38%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $53.82
Upside: +57.93%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $21.46
Upside: +63.09%
Feb 26, 2025
Reiterates: Neutral
Price Target: $4
Current: $6.92
Upside: -42.20%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $7.71
Upside: +872.76%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $26.90
Upside: +178.81%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $0.29
Upside: +2,631.31%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $1.48
Upside: +372.97%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $6.53
Upside: +53.14%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $2.68
Upside: +1,392.54%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.92
Upside: +16,254.12%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $16.73
Upside: +258.64%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $4.30
Upside: +248.84%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.74
Upside: +2,198.85%